Relevance tier by entity

Entity Tier Description
DLBCL 2 Role of PCLO mutations in DLBCL requires confirmation
MZL 1 High-confidence MZL gene
PMBL 2 Role of PCLO mutations in PMBL requires confirmation

Mutation incidence in large patient cohorts (GAMBL reanalysis)

Entity source frequency (%)
DLBCL GAMBL genomes 16.44
DLBCL Schmitz cohort 21.28
DLBCL Reddy cohort 15.12
DLBCL Chapuy cohort 23.08
FL GAMBL genomes 9.24

Mutation pattern and selective pressure estimates

Entity Missense dN/dS Nonsense dN/dS Q value
BL 4.0059 3.1731 1.0000
FL 1.0614 0.7042 1.0000
DLBCL 0.0000 0.0000 0.9986

PCLO Hotspots

Chromosome Coordinate (hg19) ref>alt HGVSp
chr7 82585303 G>T L1656I
chr7 82585302 A>G L1656P
chr7 82544727 T>C K4192R

Visualizations

Protein

View coding variants in ProteinPaint hg19 or hg38

Genome

View all variants in GenomePaint hg19 or hg38

Expression

History

%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%% timeline title Publication timing 2012-03-06 : Lohr : DLBCL

References

1.
Lohr JG, Stojanov P, Lawrence MS, Auclair D, Chapuy B, Sougnez C, Cruz-Gordillo P, Knoechel B, Asmann YW, Slager SL, Novak AJ, Dogan A, Ansell SM, Link BK, Zou L, Gould J, Saksena G, Stransky N, Rangel-Escareño C, Fernandez-Lopez JC, Hidalgo-Miranda A, Melendez-Zajgla J, Hernández-Lemus E, Schwarz-Cruz y Celis A, Imaz-Rosshandler I, Ojesina AI, Jung J, Pedamallu CS, Lander ES, Habermann TM, Cerhan JR, Shipp MA, Getz G, Golub TR. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3879–3884. PMCID: PMC3309757